๐๏ธ Verified NIH Record โข Updated 2026-08-17
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer (NCT06792695)
๐ข Recruiting Phase2 ๐ Investigational Drug / Biologic Sponsor: AstraZeneca
๐ฉบ Plain-English Summary (8th-Grade Level)
The main purpose of this study is to evaluate the safety and efficacy of novel study interventions and combinations in participants with Colorectal Cancer (CRC).
Who can join: Review the eligibility criteria below.
Location: Research Site โ Scottsdale, Arizona
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (76 Sites)
- Research Site โ Scottsdale, Arizona
- Research Site โ Los Angeles, California
- Research Site โ Washington D.C., District of Columbia
- Research Site โ Chicago, Illinois
- Research Site โ Baltimore, Maryland
- Research Site โ Boston, Massachusetts
- Research Site โ Rochester, Minnesota
- Research Site โ Trenton, New Jersey
- Research Site โ Rochester, New York
- Research Site โ Cleveland, Ohio
- Research Site โ Portland, Oregon
- Research Site โ Philadelphia, Pennsylvania
- Research Site โ Nashville, Tennessee
- Research Site โ Houston, Texas
- Research Site โ East Melbourne,
- Research Site โ Wollongong,
- Research Site โ Woodville South,
- Research Site โ Victoria, British Columbia
- Research Site โ Barrie, Ontario
- Research Site โ Toronto, Ontario
- Research Site โ Montreal, Quebec
- Research Site โ Beijing,
- Research Site โ Chengdu,
- Research Site โ Harbin,
- Research Site โ Shanghai,
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.